$SYRS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Syros Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Syros Pharmaceuticals, Inc.. Get notifications about new insider transactions in Syros Pharmaceuticals, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 17 2021 | SYRS | Syros Pharmaceutic ... | Olson Eric R | Chief Scientific Of ... | Option Exercise | M | 1.01 | 3,628 | 3,664 | 90,697 | |
Mar 17 2021 | SYRS | Syros Pharmaceutic ... | Olson Eric R | Chief Scientific Of ... | Sell | S | 9.47 | 3,628 | 34,372 | 0 | 3.6 K to 0 (-100.00 %) |
Mar 17 2021 | SYRS | Syros Pharmaceutic ... | Olson Eric R | Chief Scientific Of ... | Buy | M | 1.01 | 3,628 | 3,664 | 3,628 | 0 to 3.6 K |
Feb 19 2021 | SYRS | Syros Pharmaceutic ... | Springhorn Jeremy P. | Chief Business Offi ... | Option Exercise | A | 11.41 | 94,000 | 1,072,540 | 94,000 | |
Feb 19 2021 | SYRS | Syros Pharmaceutic ... | Olson Eric R | Chief Scientific Of ... | Option Exercise | A | 11.41 | 94,000 | 1,072,540 | 94,000 | |
Feb 19 2021 | SYRS | Syros Pharmaceutic ... | Roth David | Chief Medical Offic ... | Option Exercise | A | 11.41 | 119,000 | 1,357,790 | 119,000 | |
Feb 19 2021 | SYRS | Syros Pharmaceutic ... | Ferra Joseph J Jr | Chief Financial Off ... | Option Exercise | A | 11.41 | 119,000 | 1,357,790 | 119,000 | |
Feb 19 2021 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Option Exercise | A | 11.41 | 304,000 | 3,468,640 | 304,000 | |
Feb 18 2021 | SYRS | Syros Pharmaceutic ... | Young Richard A | Director | Sell | S | 12.05 | 3,750 | 45,188 | 321,711 | 325.5 K to 321.7 K (-1.15 %) |
Feb 10 2021 | SYRS | Syros Pharmaceutic ... | Young Richard A | Director | Sell | S | 13.04 | 3,750 | 48,900 | 325,461 | 329.2 K to 325.5 K (-1.14 %) |
Dec 21 2020 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Option Exercise | M | 10.09 | 4,988 | 50,329 | 280,012 | |
Dec 21 2020 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Option Exercise | M | 8.51 | 14,168 | 120,570 | 79,165 | |
Dec 21 2020 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Option Exercise | M | 3.04 | 10,761 | 32,713 | 21,524 | |
Dec 21 2020 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Buy | M | 10.09 | 4,988 | 50,329 | 563,606 | 558.6 K to 563.6 K (+0.89 %) |
Dec 21 2020 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Buy | M | 8.51 | 14,168 | 120,570 | 558,618 | 544.5 K to 558.6 K (+2.60 %) |
Dec 21 2020 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Buy | M | 3.04 | 10,761 | 32,713 | 544,450 | 533.7 K to 544.5 K (+2.02 %) |
Dec 11 2020 | SYRS | Syros Pharmaceutic ... | AKKARAJU SRINIVAS | Director | Option Exercise | A | 11.00 | 156,250 | 1,718,750 | 156,250 | |
Dec 11 2020 | SYRS | Syros Pharmaceutic ... | AKKARAJU SRINIVAS | Director | Grant | A | 0.00 | 625,000 | 0 | 1,899,616 | 1.3 M to 1.9 M (+49.03 %) |
Oct 16 2020 | SYRS | Syros Pharmaceutic ... | Young Richard A | Director | Sell | S | 8.75 | 317 | 2,774 | 340,874 | 341.2 K to 340.9 K (-0.09 %) |
Sep 16 2020 | SYRS | Syros Pharmaceutic ... | Young Richard A | Director | Sell | S | 10.39 | 5,990 | 62,236 | 341,191 | 347.2 K to 341.2 K (-1.73 %) |
Sep 09 2020 | SYRS | Syros Pharmaceutic ... | Eckhardt Sue Gail | Director | Option Exercise | A | 8.94 | 35,000 | 312,900 | 35,000 | |
Aug 19 2020 | SYRS | Syros Pharmaceutic ... | Olson Eric R | Chief Scientific Of ... | Option Exercise | M | 1.01 | 10,787 | 10,895 | 94,325 | |
Aug 19 2020 | SYRS | Syros Pharmaceutic ... | Olson Eric R | Chief Scientific Of ... | Option Exercise | M | 1.01 | 4,963 | 5,013 | 105,112 | |
Aug 19 2020 | SYRS | Syros Pharmaceutic ... | Olson Eric R | Chief Scientific Of ... | Sell | S | 13.00 | 10,787 | 140,231 | 0 | 10.8 K to 0 (-100.00 %) |
Aug 19 2020 | SYRS | Syros Pharmaceutic ... | Olson Eric R | Chief Scientific Of ... | Buy | M | 1.01 | 10,787 | 10,895 | 10,787 | 0 to 10.8 K |
Aug 19 2020 | SYRS | Syros Pharmaceutic ... | Olson Eric R | Chief Scientific Of ... | Sell | S | 13.00 | 4,963 | 64,519 | 0 | 5 K to 0 (-100.00 %) |
Aug 19 2020 | SYRS | Syros Pharmaceutic ... | Olson Eric R | Chief Scientific Of ... | Buy | M | 1.01 | 4,963 | 5,013 | 4,963 | 0 to 5 K |
Aug 19 2020 | SYRS | Syros Pharmaceutic ... | Young Richard A | Director | Sell | S | 12.59 | 5,990 | 75,414 | 347,181 | 353.2 K to 347.2 K (-1.70 %) |
Aug 19 2020 | SYRS | Syros Pharmaceutic ... | AKKARAJU SRINIVAS | Director | Sell | S | 13.10 | 158,583 | 2,076,724 | 1,274,616 | 1.4 M to 1.3 M (-11.06 %) |
Aug 19 2020 | SYRS | Syros Pharmaceutic ... | AKKARAJU SRINIVAS | Director | Sell | S | 13.00 | 744 | 9,672 | 1,433,199 | 1.4 M to 1.4 M (-0.05 %) |
Jul 17 2020 | SYRS | Syros Pharmaceutic ... | Young Richard A | Director | Sell | S | 11.85 | 5,990 | 70,982 | 353,171 | 359.2 K to 353.2 K (-1.67 %) |
Jul 07 2020 | SYRS | Syros Pharmaceutic ... | Olson Eric R | Chief Scientific Of ... | Sell | S | 11.72 | 1,753 | 20,538 | 0 | 1.8 K to 0 (-100.00 %) |
Jul 06 2020 | SYRS | Syros Pharmaceutic ... | AKKARAJU SRINIVAS | Director | Sell | S | 11.01 | 4,627 | 50,966 | 1,433,943 | 1.4 M to 1.4 M (-0.32 %) |
Jun 25 2020 | SYRS | Syros Pharmaceutic ... | AKKARAJU SRINIVAS | Director | Sell | S | 11.15 | 54,972 | 612,850 | 1,438,570 | 1.5 M to 1.4 M (-3.68 %) |
Jun 25 2020 | SYRS | Syros Pharmaceutic ... | AKKARAJU SRINIVAS | Director | Sell | S | 11.07 | 48,775 | 539,788 | 1,493,542 | 1.5 M to 1.5 M (-3.16 %) |
Jun 25 2020 | SYRS | Syros Pharmaceutic ... | AKKARAJU SRINIVAS | Director | Sell | S | 11.11 | 50,953 | 565,930 | 1,542,317 | 1.6 M to 1.5 M (-3.20 %) |
Jun 25 2020 | SYRS | Syros Pharmaceutic ... | AKKARAJU SRINIVAS | Director | Sell | S | 11.15 | 54,972 | 612,850 | 1,438,570 | 1.5 M to 1.4 M (-3.68 %) |
Jun 25 2020 | SYRS | Syros Pharmaceutic ... | AKKARAJU SRINIVAS | Director | Sell | S | 11.07 | 48,775 | 539,788 | 1,493,542 | 1.5 M to 1.5 M (-3.16 %) |
Jun 25 2020 | SYRS | Syros Pharmaceutic ... | AKKARAJU SRINIVAS | Director | Sell | S | 11.11 | 50,953 | 565,930 | 1,542,317 | 1.6 M to 1.5 M (-3.20 %) |
Jun 16 2020 | SYRS | Syros Pharmaceutic ... | Young Richard A | Director | Sell | S | 8.75 | 5,990 | 52,413 | 359,161 | 365.2 K to 359.2 K (-1.64 %) |
Jun 16 2020 | SYRS | Syros Pharmaceutic ... | Young Richard A | Director | Sell | S | 8.75 | 5,990 | 52,413 | 359,161 | 365.2 K to 359.2 K (-1.64 %) |
Jun 11 2020 | SYRS | Syros Pharmaceutic ... | Young Richard A | Director | Option Exercise | A | 9.17 | 17,500 | 160,475 | 17,500 | |
Jun 11 2020 | SYRS | Syros Pharmaceutic ... | WIRTH PETER | Director | Option Exercise | A | 9.17 | 17,500 | 160,475 | 17,500 | |
Jun 11 2020 | SYRS | Syros Pharmaceutic ... | SHARP PHILLIP A | Director | Option Exercise | A | 9.17 | 17,500 | 160,475 | 17,500 | |
Jun 11 2020 | SYRS | Syros Pharmaceutic ... | Nashat Amir | Director | Option Exercise | A | 9.17 | 17,500 | 160,475 | 17,500 | |
Jun 11 2020 | SYRS | Syros Pharmaceutic ... | Young Richard A | Director | Option Exercise | A | 9.17 | 17,500 | 160,475 | 17,500 | |
Jun 11 2020 | SYRS | Syros Pharmaceutic ... | WIRTH PETER | Director | Option Exercise | A | 9.17 | 17,500 | 160,475 | 17,500 | |
Jun 11 2020 | SYRS | Syros Pharmaceutic ... | SHARP PHILLIP A | Director | Option Exercise | A | 9.17 | 17,500 | 160,475 | 17,500 | |
Jun 11 2020 | SYRS | Syros Pharmaceutic ... | Nashat Amir | Director | Option Exercise | A | 9.17 | 17,500 | 160,475 | 17,500 | |
Jun 11 2020 | SYRS | Syros Pharmaceutic ... | Fanucci Marsha | Director | Option Exercise | A | 9.17 | 17,500 | 160,475 | 17,500 | |
Jun 11 2020 | SYRS | Syros Pharmaceutic ... | Alles Mark J | Director | Option Exercise | A | 9.17 | 17,500 | 160,475 | 17,500 | |
Jun 11 2020 | SYRS | Syros Pharmaceutic ... | AKKARAJU SRINIVAS | Director | Option Exercise | A | 9.17 | 17,500 | 160,475 | 17,500 | |
May 15 2020 | SYRS | Syros Pharmaceutic ... | Young Richard A | Director | Sell | S | 9.22 | 5,990 | 55,242 | 365,151 | 371.1 K to 365.2 K (-1.61 %) |
May 13 2020 | SYRS | Syros Pharmaceutic ... | Alles Mark J | Director | Buy | P | 8.86 | 10,000 | 88,590 | 10,000 | 0 to 10 K |
Apr 17 2020 | SYRS | Syros Pharmaceutic ... | Young Richard A | Director | Sell | S | 8.75 | 23,960 | 209,650 | 371,141 | 395.1 K to 371.1 K (-6.06 %) |
Feb 14 2020 | SYRS | Syros Pharmaceutic ... | Springhorn Jeremy P. | Chief Business Offi ... | Option Exercise | A | 7.54 | 94,000 | 708,760 | 94,000 | |
Feb 14 2020 | SYRS | Syros Pharmaceutic ... | Roth David | Chief Medical Offic ... | Option Exercise | A | 7.54 | 94,000 | 708,760 | 94,000 | |
Feb 14 2020 | SYRS | Syros Pharmaceutic ... | Olson Eric R | Chief Scientific Of ... | Option Exercise | A | 7.54 | 94,000 | 708,760 | 94,000 | |
Feb 14 2020 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Option Exercise | A | 7.54 | 294,000 | 2,216,760 | 294,000 | |
Dec 23 2019 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Option Exercise | M | 3.04 | 8,210 | 24,958 | 1,018,123 | |
Dec 23 2019 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Option Exercise | M | 3.04 | 10,762 | 32,716 | 1,026,333 | |
Dec 23 2019 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Option Exercise | M | 3.04 | 33,429 | 101,624 | 1,037,095 | |
Dec 23 2019 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Buy | M | 3.04 | 52,401 | 159,299 | 533,689 | 481.3 K to 533.7 K (+10.89 %) |
Dec 23 2019 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Option Exercise | M | 3.04 | 8,210 | 24,958 | 1,018,123 | |
Dec 23 2019 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Option Exercise | M | 3.04 | 10,762 | 32,716 | 1,026,333 | |
Dec 23 2019 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Option Exercise | M | 3.04 | 33,429 | 101,624 | 1,037,095 | |
Dec 23 2019 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Buy | M | 3.04 | 52,401 | 159,299 | 533,689 | 481.3 K to 533.7 K (+10.89 %) |
Dec 20 2019 | SYRS | Syros Pharmaceutic ... | Alles Mark J | Director | Option Exercise | A | 6.22 | 35,000 | 217,700 | 35,000 | |
Aug 19 2019 | SYRS | Syros Pharmaceutic ... | Young Richard A | Director | Sell | S | 10.00 | 22,700 | 227,000 | 395,101 | 417.8 K to 395.1 K (-5.43 %) |
Aug 19 2019 | SYRS | Syros Pharmaceutic ... | Young Richard A | Director | Sell | S | 10.00 | 2,300 | 23,000 | 417,801 | 420.1 K to 417.8 K (-0.55 %) |
Jul 17 2019 | SYRS | Syros Pharmaceutic ... | ARCH Venture Fund VII, L.P. | 10% Owner | Sell | S | 7.70 | 34,521 | 265,687 | 4,242,051 | 4.3 M to 4.2 M (-0.81 %) |
Jul 17 2019 | SYRS | Syros Pharmaceutic ... | ARCH Venture Fund VII, L.P. | 10% Owner | Sell | S | 7.81 | 25,779 | 201,277 | 4,276,572 | 4.3 M to 4.3 M (-0.60 %) |
Jul 17 2019 | SYRS | Syros Pharmaceutic ... | ARCH Venture Fund VII, L.P. | 10% Owner | Sell | S | 8.27 | 2,700 | 22,316 | 4,302,051 | 4.3 M to 4.3 M (-0.06 %) |
Jun 12 2019 | SYRS | Syros Pharmaceutic ... | Young Richard A | Director | Option Exercise | A | 5.60 | 11,000 | 61,600 | 11,000 | |
Jun 12 2019 | SYRS | Syros Pharmaceutic ... | WIRTH PETER | Director | Option Exercise | A | 5.60 | 11,000 | 61,600 | 11,000 | |
Jun 12 2019 | SYRS | Syros Pharmaceutic ... | Shaw Alice Tsang | Director | Option Exercise | A | 5.60 | 22,000 | 123,200 | 22,000 | |
Jun 12 2019 | SYRS | Syros Pharmaceutic ... | SHARP PHILIP A | Director | Option Exercise | A | 5.60 | 11,000 | 61,600 | 11,000 | |
Jun 12 2019 | SYRS | Syros Pharmaceutic ... | SATO VICKI L | Director | Option Exercise | A | 5.60 | 11,000 | 61,600 | 11,000 | |
Jun 12 2019 | SYRS | Syros Pharmaceutic ... | Nashat Amir | Director | Option Exercise | A | 5.60 | 11,000 | 61,600 | 11,000 | |
Jun 12 2019 | SYRS | Syros Pharmaceutic ... | Fanucci Marsha | Director | Option Exercise | A | 5.60 | 11,000 | 61,600 | 11,000 | |
Jun 12 2019 | SYRS | Syros Pharmaceutic ... | AKKARAJU SRINIVAS | Director | Option Exercise | A | 5.60 | 11,000 | 61,600 | 11,000 | |
Apr 11 2019 | SYRS | Syros Pharmaceutic ... | AKKARAJU SRINIVAS | Director | Option Exercise | P | 8.63 | 133,333 | 1,149,997 | 133,333 | |
Apr 11 2019 | SYRS | Syros Pharmaceutic ... | AKKARAJU SRINIVAS | Director | Buy | P | 7.50 | 533,332 | 3,999,990 | 1,593,270 | 1.1 M to 1.6 M (+50.32 %) |
Mar 14 2019 | SYRS | Syros Pharmaceutic ... | ARCH Venture Fund VII, L.P. | 10% Owner | Sell | S | 8.15 | 43,000 | 350,441 | 4,305,051 | 4.3 M to 4.3 M (-0.99 %) |
Mar 14 2019 | SYRS | Syros Pharmaceutic ... | ARCH Venture Fund VII, L.P. | 10% Owner | Sell | S | 8.20 | 2,820 | 23,122 | 4,348,051 | 4.4 M to 4.3 M (-0.06 %) |
Mar 14 2019 | SYRS | Syros Pharmaceutic ... | ARCH Venture Fund VII, L.P. | 10% Owner | Sell | S | 7.89 | 81,591 | 643,443 | 4,350,871 | 4.4 M to 4.4 M (-1.84 %) |
Mar 14 2019 | SYRS | Syros Pharmaceutic ... | ARCH Venture Fund VII, L.P. | 10% Owner | Sell | S | 7.37 | 40,092 | 295,374 | 4,432,462 | 4.5 M to 4.4 M (-0.90 %) |
Mar 11 2019 | SYRS | Syros Pharmaceutic ... | ARCH Venture Fund VII, L.P. | 10% Owner | Sell | S | 6.49 | 44,878 | 291,366 | 4,472,554 | 4.5 M to 4.5 M (-0.99 %) |
Mar 11 2019 | SYRS | Syros Pharmaceutic ... | ARCH Venture Fund VII, L.P. | 10% Owner | Sell | S | 6.93 | 84,496 | 585,270 | 4,517,432 | 4.6 M to 4.5 M (-1.84 %) |
Mar 11 2019 | SYRS | Syros Pharmaceutic ... | ARCH Venture Fund VII, L.P. | 10% Owner | Sell | S | 6.87 | 35,209 | 242,013 | 4,601,928 | 4.6 M to 4.6 M (-0.76 %) |
Dec 03 2018 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Option Exercise | M | 3.04 | 12,084 | 36,735 | 785,523 | |
Dec 03 2018 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Option Exercise | M | 1.01 | 75,050 | 75,801 | 797,607 | |
Dec 03 2018 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Option Exercise | M | 1.01 | 23,454 | 23,689 | 872,657 | |
Dec 03 2018 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Buy | M | 3.04 | 12,084 | 36,735 | 481,288 | 469.2 K to 481.3 K (+2.58 %) |
Dec 03 2018 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Buy | M | 1.01 | 98,504 | 99,489 | 469,204 | 370.7 K to 469.2 K (+26.57 %) |
Jun 15 2018 | SYRS | Syros Pharmaceutic ... | Young Richard A | Director | Option Exercise | A | 12.95 | 11,000 | 142,450 | 11,000 | |
Jun 15 2018 | SYRS | Syros Pharmaceutic ... | WIRTH PETER | Director | Option Exercise | A | 12.95 | 11,000 | 142,450 | 11,000 | |
Jun 15 2018 | SYRS | Syros Pharmaceutic ... | SHARP PHILIP A | Director | Option Exercise | A | 12.95 | 11,000 | 142,450 | 11,000 | |
Jun 15 2018 | SYRS | Syros Pharmaceutic ... | SATO VICKI L | Director | Option Exercise | A | 12.95 | 11,000 | 142,450 | 11,000 | |
Jun 15 2018 | SYRS | Syros Pharmaceutic ... | Nashat Amir | Director | Option Exercise | A | 12.95 | 11,000 | 142,450 | 11,000 | |
Jun 15 2018 | SYRS | Syros Pharmaceutic ... | Fanucci Marsha | Director | Option Exercise | A | 12.95 | 11,000 | 142,450 | 11,000 | |
Jun 15 2018 | SYRS | Syros Pharmaceutic ... | BONNEY MICHAEL W | Director | Option Exercise | A | 12.95 | 13,000 | 168,350 | 13,000 | |
Jun 15 2018 | SYRS | Syros Pharmaceutic ... | AKKARAJU SRINIVAS | Director | Option Exercise | A | 12.95 | 11,000 | 142,450 | 11,000 | |
Mar 12 2018 | SYRS | Syros Pharmaceutic ... | Ferra Joseph J Jr | Chief Financial Off ... | Option Exercise | A | 12.32 | 50,000 | 616,000 | 50,000 | |
Mar 12 2018 | SYRS | Syros Pharmaceutic ... | Ferra Joseph J Jr | Chief Financial Off ... | Option Exercise | A | 12.32 | 150,000 | 1,848,000 | 150,000 | |
Feb 21 2018 | SYRS | Syros Pharmaceutic ... | Quirk Gerald E | Chief Legal Officer | Option Exercise | A | 13.30 | 11,666 | 155,158 | 11,666 | |
Feb 21 2018 | SYRS | Syros Pharmaceutic ... | Quirk Gerald E | Chief Legal Officer | Option Exercise | A | 10.09 | 75,000 | 756,750 | 75,000 | |
Feb 21 2018 | SYRS | Syros Pharmaceutic ... | Roth David | Chief Medical Offic ... | Option Exercise | A | 10.09 | 75,000 | 756,750 | 75,000 | |
Feb 21 2018 | SYRS | Syros Pharmaceutic ... | Olson Eric R | Chief Scientific Of ... | Option Exercise | A | 10.09 | 75,000 | 756,750 | 75,000 | |
Feb 21 2018 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Option Exercise | A | 10.09 | 285,000 | 2,875,650 | 285,000 | |
Feb 02 2018 | SYRS | Syros Pharmaceutic ... | AKKARAJU SRINIVAS | Director | Buy | P | 9.55 | 209,424 | 1,999,999 | 1,059,938 | 850.5 K to 1.1 M (+24.62 %) |
Dec 15 2017 | SYRS | Syros Pharmaceutic ... | Springhorn Jeremy P. | Chief Business Offi ... | Buy | P | 9.08 | 15,000 | 136,260 | 15,000 | 0 to 15 K |
Dec 14 2017 | SYRS | Syros Pharmaceutic ... | AKKARAJU SRINIVAS | Director | Buy | P | 8.99 | 26,600 | 239,134 | 830,494 | 803.9 K to 830.5 K (+3.31 %) |
Dec 14 2017 | SYRS | Syros Pharmaceutic ... | AKKARAJU SRINIVAS | Director | Buy | P | 8.97 | 68,400 | 613,548 | 803,894 | 735.5 K to 803.9 K (+9.30 %) |
Dec 14 2017 | SYRS | Syros Pharmaceutic ... | AKKARAJU SRINIVAS | Director | Buy | P | 9.40 | 14,774 | 138,876 | 735,494 | 720.7 K to 735.5 K (+2.05 %) |
Nov 14 2017 | SYRS | Syros Pharmaceutic ... | Springhorn Jeremy P. | Chief Business Offi ... | Option Exercise | A | 11.65 | 50,000 | 582,500 | 50,000 | |
Nov 14 2017 | SYRS | Syros Pharmaceutic ... | Springhorn Jeremy P. | Chief Business Offi ... | Option Exercise | A | 11.65 | 150,000 | 1,747,500 | 150,000 | |
Oct 23 2017 | SYRS | Syros Pharmaceutic ... | DeSimone Colleen Elizabeth | Principal Accountin ... | Option Exercise | M | 3.04 | 550 | 1,672 | 13,016 | |
Oct 23 2017 | SYRS | Syros Pharmaceutic ... | DeSimone Colleen Elizabeth | Principal Accountin ... | Sell | S | 16.06 | 550 | 8,833 | 0 | 550 to 0 (-100.00 %) |
Oct 23 2017 | SYRS | Syros Pharmaceutic ... | DeSimone Colleen Elizabeth | Principal Accountin ... | Buy | M | 3.04 | 550 | 1,672 | 550 | 0 to 550 |
Aug 21 2017 | SYRS | Syros Pharmaceutic ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | J | 0.00 | 54,293 | 0 | 0 | 54.3 K to 0 (-100.00 %) |
Aug 21 2017 | SYRS | Syros Pharmaceutic ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | J | 0.00 | 306,222 | 0 | 612,442 | 918.7 K to 612.4 K (-33.33 %) |
Aug 21 2017 | SYRS | Syros Pharmaceutic ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | J | 0.00 | 1,295,997 | 0 | 2,378,663 | 3.7 M to 2.4 M (-35.27 %) |
Aug 16 2017 | SYRS | Syros Pharmaceutic ... | Young Richard A | Director | Sell | S | 22.00 | 3,282 | 72,204 | 420,101 | 423.4 K to 420.1 K (-0.78 %) |
Aug 08 2017 | SYRS | Syros Pharmaceutic ... | Olson Eric R | Chief Scientific Of ... | Option Exercise | M | 1.01 | 2,500 | 2,525 | 110,075 | |
Aug 08 2017 | SYRS | Syros Pharmaceutic ... | Olson Eric R | Chief Scientific Of ... | Sell | S | 23.59 | 2,500 | 58,969 | 0 | 2.5 K to 0 (-100.00 %) |
Aug 08 2017 | SYRS | Syros Pharmaceutic ... | Olson Eric R | Chief Scientific Of ... | Buy | M | 1.01 | 2,500 | 2,525 | 2,500 | 0 to 2.5 K |
Jul 27 2017 | SYRS | Syros Pharmaceutic ... | Olson Eric R | Chief Scientific Of ... | Option Exercise | M | 1.01 | 12,500 | 12,625 | 25,025 | |
Jul 27 2017 | SYRS | Syros Pharmaceutic ... | Olson Eric R | Chief Scientific Of ... | Sell | S | 21.85 | 12,500 | 273,125 | 0 | 12.5 K to 0 (-100.00 %) |
Jul 27 2017 | SYRS | Syros Pharmaceutic ... | Olson Eric R | Chief Scientific Of ... | Buy | M | 1.01 | 12,500 | 12,625 | 12,500 | 0 to 12.5 K |
Jul 27 2017 | SYRS | Syros Pharmaceutic ... | Young Richard A | Director | Sell | S | 22.09 | 3,282 | 72,496 | 423,383 | 426.7 K to 423.4 K (-0.77 %) |
Jun 12 2017 | SYRS | Syros Pharmaceutic ... | AKKARAJU SRINIVAS | Director | Option Exercise | A | 14.26 | 22,000 | 313,720 | 22,000 | |
Jun 12 2017 | SYRS | Syros Pharmaceutic ... | Fanucci Marsha | Director | Option Exercise | A | 14.26 | 11,000 | 156,860 | 11,000 | |
Jun 12 2017 | SYRS | Syros Pharmaceutic ... | Nashat Amir | Director | Option Exercise | A | 14.26 | 11,000 | 156,860 | 11,000 | |
Jun 12 2017 | SYRS | Syros Pharmaceutic ... | Patel Sanj K | Director | Option Exercise | A | 14.26 | 11,000 | 156,860 | 11,000 | |
Jun 12 2017 | SYRS | Syros Pharmaceutic ... | NELSEN ROBERT | Director | Option Exercise | A | 14.26 | 11,000 | 156,860 | 11,000 | |
Jun 12 2017 | SYRS | Syros Pharmaceutic ... | SATO VICKI L | Director | Option Exercise | A | 14.26 | 11,000 | 156,860 | 11,000 | |
Jun 12 2017 | SYRS | Syros Pharmaceutic ... | SHARP PHILIP A | Director | Option Exercise | A | 14.26 | 11,000 | 156,860 | 11,000 | |
Jun 12 2017 | SYRS | Syros Pharmaceutic ... | Young Richard A | Director | Option Exercise | A | 14.26 | 11,000 | 156,860 | 11,000 | |
Feb 13 2017 | SYRS | Syros Pharmaceutic ... | Kuvalanka Kyle D. | Chief Operating Off ... | Option Exercise | A | 10.90 | 78,000 | 850,200 | 78,000 | |
Feb 13 2017 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Option Exercise | A | 10.90 | 175,000 | 1,907,500 | 175,000 | |
Feb 13 2017 | SYRS | Syros Pharmaceutic ... | Olson Eric R | Chief Scientific Of ... | Option Exercise | A | 10.90 | 63,500 | 692,150 | 63,500 | |
Feb 13 2017 | SYRS | Syros Pharmaceutic ... | Quirk Gerald E | Chief Legal Officer | Option Exercise | A | 10.90 | 40,000 | 436,000 | 40,000 | |
Jan 30 2017 | SYRS | Syros Pharmaceutic ... | WIRTH PETER | Director | Option Exercise | A | 10.76 | 22,000 | 236,720 | 22,000 | |
Sep 29 2016 | SYRS | Syros Pharmaceutic ... | Quirk Gerald E | Chief Legal Officer | Option Exercise | A | 13.30 | 105,000 | 1,396,500 | 105,000 | |
Sep 19 2016 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Option Exercise | A | 12.17 | 75,000 | 912,750 | 75,000 | |
Sep 19 2016 | SYRS | Syros Pharmaceutic ... | SATO VICKI L | Director | Option Exercise | A | 12.59 | 22,000 | 276,980 | 22,000 | |
Sep 19 2016 | SYRS | Syros Pharmaceutic ... | Patel Sanj K | Director | Option Exercise | A | 12.59 | 22,000 | 276,980 | 22,000 | |
Sep 19 2016 | SYRS | Syros Pharmaceutic ... | SHARP PHILIP A | Director | Option Exercise | A | 12.59 | 22,000 | 276,980 | 22,000 | |
Sep 19 2016 | SYRS | Syros Pharmaceutic ... | Nashat Amir | Director | Option Exercise | A | 12.59 | 22,000 | 276,980 | 22,000 |